Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Long-Term Investments (2021)

Immuneering has reported Long-Term Investments over the past 1 years, most recently at $996560.0 for Q4 2021.

  • Quarterly results put Long-Term Investments at $996560.0 for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $996560.0 (changed N/A YoY), and the annual figure for FY2021 was $996560.0, changed.
  • Long-Term Investments for Q4 2021 was $996560.0 at Immuneering, down from $10.1 million in the prior quarter.
  • Over the last five years, Long-Term Investments for IMRX hit a ceiling of $10.1 million in Q3 2021 and a floor of $996560.0 in Q4 2021.